Adaptimmune Therapeutics PLC (ADAP)
1.38
+0.09
(+6.98%)
USD |
NASDAQ |
Jul 26, 16:00
1.42
+0.04
(+2.90%)
After-Hours: 20:00
Adaptimmune Therapeutics Max Drawdown (5Y): 96.57% for June 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
June 30, 2024 | 96.57% |
May 31, 2024 | 96.57% |
April 30, 2024 | 96.57% |
March 31, 2024 | 96.57% |
February 29, 2024 | 96.57% |
January 31, 2024 | 96.57% |
December 31, 2023 | 96.57% |
November 30, 2023 | 96.57% |
October 31, 2023 | 96.57% |
September 30, 2023 | 96.57% |
August 31, 2023 | 96.57% |
July 31, 2023 | 96.57% |
June 30, 2023 | 96.57% |
May 31, 2023 | 96.57% |
April 30, 2023 | 96.57% |
March 31, 2023 | 96.57% |
February 28, 2023 | 96.57% |
January 31, 2023 | 96.57% |
December 31, 2022 | 96.57% |
November 30, 2022 | 96.57% |
October 31, 2022 | 96.57% |
September 30, 2022 | 96.57% |
August 31, 2022 | 96.57% |
July 31, 2022 | 96.57% |
June 30, 2022 | 96.57% |
Date | Value |
---|---|
May 31, 2022 | 96.57% |
April 30, 2022 | 96.57% |
March 31, 2022 | 96.57% |
February 28, 2022 | 96.57% |
January 31, 2022 | 96.57% |
December 31, 2021 | 96.57% |
November 30, 2021 | 96.57% |
October 31, 2021 | 96.57% |
September 30, 2021 | 96.57% |
August 31, 2021 | 96.57% |
July 31, 2021 | 96.57% |
June 30, 2021 | 96.57% |
May 31, 2021 | 96.57% |
April 30, 2021 | 96.57% |
March 31, 2021 | 96.57% |
February 28, 2021 | 96.57% |
January 31, 2021 | 96.57% |
December 31, 2020 | 96.57% |
November 30, 2020 | 96.57% |
October 31, 2020 | 96.57% |
September 30, 2020 | 96.57% |
August 31, 2020 | 96.57% |
July 31, 2020 | 96.57% |
June 30, 2020 | 96.57% |
May 31, 2020 | 96.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
85.75%
Minimum
Jul 2019
96.57%
Maximum
Nov 2019
96.26%
Average
96.57%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
Biodexa Pharmaceuticals Plc | 100.00% |
NuCana PLC | 99.05% |
Mereo BioPharma Group PLC | 94.92% |
Autolus Therapeutics PLC | 96.58% |
TC BioPharm (Holdings) PLC | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -56.59 |
Beta (5Y) | 2.308 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 157.7% |
Historical Sharpe Ratio (5Y) | -0.1701 |
Historical Sortino (5Y) | -0.6416 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.62% |